MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1

Cancer Associated E17K Mutation Causes Rapid Conformational Drift in AKT1 Pleckstrin Homology (PH) Domain

(2013) Ambuj Kumar et al.   PLoS One

Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer

(2012) Nuria Juanpere et al.   HUMAN PATHOLOGY

A miRNA expression signature that separates between normal and malignant prostate tissues

(2011) Jessica Carlsson et al.   Cancer Cell International

Circulating miRNA signature for early diagnosis of lung cancer

(2011) Pei-Ying Lin et al.   EMBO Molecular Medicine

Sensory Neuropathy Attributable to Loss of Bcl-w

(2011) S. L. Courchesne et al.   JOURNAL OF NEUROSCIENCE

Alteration in methylation pattern of oncogene Akt1 promoter region in bladder cancer

(2011) Xiao-Feng Sun et al.   MOLECULAR BIOLOGY REPORTS

MicroRNAs, diet, and cancer: New mechanistic insights on the epigenetic actions of phytochemicals

(2011) Mansi A. Parasramka et al.   MOLECULAR CARCINOGENESIS

MicroRNAs in Brain Tumors

(2011) Richard Hummel et al.   MOLECULAR NEUROBIOLOGY

NKX2-3 Transcriptional Regulation of Endothelin-1 and VEGF Signaling in Human Intestinal Microvascular Endothelial Cells

(2011) Wei Yu et al.   PLoS One

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

(2010) T Chiyomaru et al.   BRITISH JOURNAL OF CANCER

miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo

(2010) Gui Hu et al.   CANCER BIOLOGY & THERAPY

miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

(2010) Masayuki Kano et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer

(2009) Melissa Crawford et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer

(2009) J. W.F. Catto et al.   CANCER RESEARCH

BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonists

(2009) K C Goldsmith et al.   CELL DEATH AND DIFFERENTIATION

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

(2009) Raffaele Baffa et al.   JOURNAL OF PATHOLOGY

AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K

(2009) J M Askham et al.   ONCOGENE

Bcl-2 inhibitors: small molecules with a big impact on cancer therapy

(2008) M Vogler et al.   CELL DEATH AND DIFFERENTIATION

MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31

(2008) Srinivas Veerla et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death

(2008) R Schickel et al.   ONCOGENE

A microRNA expression ratio defining the invasive phenotype in bladder tumors

(2008) Lori A. Neely et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS